The rise of European venture capital for biotechnology.
作者信息
Howell Michael, Trull Melanie, Dibner Mark D
机构信息
Curriculum in Neurobiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
出版信息
Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287.
PMID:14595356
Abstract
摘要
相似文献
1
The rise of European venture capital for biotechnology.
Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287.
2
Mixed results in Q1.
Nat Biotechnol. 2005 May;23(5):518. doi: 10.1038/nbt0505-518.
3
VC funding hits high in Q1.
Nat Biotechnol. 2007 May;25(5):496. doi: 10.1038/nbt0507-496.
4
2006: a stellar year for financing.
Nat Biotechnol. 2007 Feb;25(2):156. doi: 10.1038/nbt0207-156.
5
Looking at US versus European exit opportunities.
Nat Biotechnol. 2005 Oct;23(10):1203.
6
Biotech financing retrenches in Q2.
Nat Biotechnol. 2006 Aug;24(8):883. doi: 10.1038/nbt0806-883. Epub 2006 Aug 3.
7
Biotech IPOs--flop or pop?
Nat Biotechnol. 2004 Aug;22(8):949. doi: 10.1038/nbt0804-949.
8
Mind the (biomedical funding) gap.
Nat Biotechnol. 2005 Oct;23(10):1217-8. doi: 10.1038/nbt1005-1217.
9
Enthusiasm cools in Q2.
Nat Biotechnol. 2005 Aug;23(8):914. doi: 10.1038/nbt0805-914.
10
US venture capital for biotechnology.
Nat Biotechnol. 2003 Jun;21(6):613-7. doi: 10.1038/nbt0603-613.
Zotero 插件